Apellis Pharmaceuticals, Inc. (APLS)
May 14, 2026 - APLS was delisted (reason: acquired by BIIB)
41.03
-0.03 (-0.07%)
Inactive · Last trade price on May 13, 2026
Apellis Pharmaceuticals Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 405.21 | 466.23 | 411.29 | 351.19 | 551.8 | 640.19 |
Short-Term Investments | 0.99 | 1.55 | 4.85 | 4.35 | 6.51 | 61.04 |
Cash & Short-Term Investments | 406.2 | 467.79 | 416.14 | 355.54 | 558.31 | 701.23 |
Cash Growth | 12.11% | 12.41% | 17.04% | -36.32% | -20.38% | -20.10% |
Accounts Receivable | 445.11 | 369.16 | 271.72 | 224.5 | 29.17 | 80.1 |
Other Receivables | - | - | - | - | 8.71 | - |
Receivables | 445.11 | 369.16 | 271.72 | 224.5 | 37.88 | 80.1 |
Inventory | 133.61 | 144.76 | 82.48 | 162.66 | 99.7 | 24 |
Prepaid Expenses | 17.38 | 9.52 | 9.51 | 8.59 | 7.18 | 5.17 |
Restricted Cash | 1.52 | 1.53 | 1.32 | 1.11 | 1.27 | 1.56 |
Other Current Assets | 24.2 | 22.1 | 7.78 | 13.93 | 15.18 | 11.98 |
Total Current Assets | 1,028 | 1,015 | 788.95 | 766.33 | 719.52 | 824.05 |
Property, Plant & Equipment | 20.36 | 19.9 | 19.04 | 21.09 | 24.9 | 26.08 |
Long-Term Accounts Receivable | - | - | - | - | 15 | 30 |
Other Long-Term Assets | 34.15 | 40.51 | 77.06 | 1.31 | 0.8 | 1.64 |
Total Assets | 1,083 | 1,075 | 885.05 | 788.73 | 760.22 | 881.77 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 49.05 | 56.8 | 38.57 | 37.52 | 37.34 | 16.91 |
Accrued Expenses | 133.69 | 166.05 | 140.18 | 127.81 | 95.14 | 103.24 |
Current Portion of Long-Term Debt | 93.74 | 93.66 | - | - | - | - |
Current Portion of Leases | 6.96 | 7.09 | 6.75 | 6.44 | 5.63 | 4.12 |
Other Current Liabilities | - | - | - | 75.83 | 29.5 | 7.58 |
Total Current Liabilities | 283.45 | 323.6 | 185.51 | 247.59 | 167.61 | 131.85 |
Long-Term Debt | 362.24 | 361.66 | 452.83 | 93.03 | 92.74 | 189.02 |
Long-Term Leases | 12.81 | 11.95 | 10.2 | 11.45 | 14.35 | 17.08 |
Other Long-Term Liabilities | 9.11 | 7.9 | 7.97 | 242.13 | 315.65 | 345.15 |
Total Liabilities | 667.61 | 705.11 | 656.51 | 594.21 | 590.35 | 683.1 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
Additional Paid-In Capital | 3,412 | 3,385 | 3,267 | 3,036 | 2,480 | 1,857 |
Retained Earnings | -2,994 | -3,013 | -3,035 | -2,837 | -2,309 | -1,657 |
Comprehensive Income & Other | -2.41 | -2.1 | -3.31 | -3.54 | -0.88 | -2.09 |
Total Common Equity | 414.92 | 370.15 | 228.54 | 194.52 | 169.87 | 198.66 |
Shareholders' Equity | 414.92 | 370.15 | 228.54 | 194.52 | 169.87 | 198.66 |
Total Liabilities & Equity | 1,083 | 1,075 | 885.05 | 788.73 | 760.22 | 881.77 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 475.76 | 474.36 | 469.78 | 110.93 | 112.71 | 210.22 |
Net Cash (Debt) | -69.56 | -6.57 | -53.65 | 244.61 | 445.59 | 491.01 |
Net Cash Growth | - | - | - | -45.10% | -9.25% | -1.78% |
Net Cash Per Share | -0.53 | -0.05 | -0.43 | 2.06 | 4.20 | 5.82 |
Filing Date Shares Outstanding | 128.02 | 127.83 | 125.52 | 120.58 | 111.29 | 97.73 |
Total Common Shares Outstanding | 127.92 | 126.62 | 124.5 | 119.56 | 110.77 | 97.52 |
Working Capital | 744.57 | 691.24 | 603.45 | 518.74 | 551.91 | 692.2 |
Book Value Per Share | 3.24 | 2.92 | 1.84 | 1.63 | 1.53 | 2.04 |
Tangible Book Value | 414.92 | 370.15 | 228.54 | 194.52 | 169.87 | 198.66 |
Tangible Book Value Per Share | 3.24 | 2.92 | 1.84 | 1.63 | 1.53 | 2.04 |